New: NCI-funded clinical trial search
Mednet Logo

How would you treat a patient with ER/PR positive breast cancer with a single site of bone metastasis?

Is your approach different for oligometastatic versus oligoprogressive disease? If there is concurrent locally advanced disease, would you treat simultaneously?
2 Answers
Mednet MemberInvited Expert
Medical Oncology · UCSF Medical Center
Answered on

I would still treat with hormone therapy and a CDK 4/6 inhibitor. Not clear if the question refers to denovo disease or not. I generally do not treat asymptomatic bone mets with radiation, as there are late effects in patients who have a relatively long life expectancy and no data to suggest that radiating a single site will improve survival. If we are combining immunotherapy in the future that might change! For denovo disease it very much depends on tumor biology and extent of local disease as well as age. In general I would use a hormone based approach, although I would be sure to document by biopsy the focus of metastatic disease.

Join for free or sign in to see the full answer

Mednet Member
Medical Oncology · Private Practice and Digital Health
Answered on
Endocrine therapy is key, a CDK 4/6 inhibitor might best be reserved for resistant disease. These are hormone-dependent indolent cancers typically and an endocrine agent will be sufficient initially.

Join for free or sign in to see the full answer